跳至主要内容
临床试验/NCT02380768
NCT02380768已完成不适用

A Randomized Comparison of the Ambu AuraGain™ and LMA Supreme™ in Infants and Children

Ann & Robert H Lurie Children's Hospital of Chicago1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Oropharyngeal (airway) leak pressure - Initial

研究概览

简要总结

The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.

详细描述

The goal of this prospective randomized study is to compare whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain (sizes 1.5 and 2) and the Laryngeal Mask Airway (LMA) Supreme. Parameters of clinical relevance such as insertion success rates, fiberoptic view of the glottic opening, ease and speed of gastric tube placement, airway stability, and peri-operative complications will also be assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
3 Months 至 6 Years(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Scheduled for surgery utilizing a supraglottic airway device
  • •ASA (American Society of Anesthesiologists) I-III classification
  • •Weighing between 5 - 20 kilograms

排除标准

  • •Active respiratory infection
  • •History of difficult mask ventilation
  • •Diagnosis of congenital syndrome with difficult airway management
  • •Active gastrointestinal reflux
  • •Coagulopathy
  • •Significant Pulmonary disease
  • •Emergent surgery

研究组 & 干预措施

Ambu AuraGain

Experimental

Subjects will receive the Ambu AuraGain size 1.5 or 2.0 based on manufacturer guidelines

干预措施: Ambu AuraGain (size 1.5 or size 2.0) (Device)

LMA Supreme

Active Comparator

Subjects will receive the Ambu AuraGain size 1.5 or 2.0 based on manufacturer guidelines

干预措施: LMA Supreme (size 1.5 or size 2.0) (Device)

结局指标

主要结局

Oropharyngeal (airway) leak pressure - Initial

时间窗: Assessed intraoperatively at the time of confirmed device placement

The airway pressure at which an airway leak is observed after successful placement of the supraglottic airway

Oropharyngeal (airway) leak pressure - 10 Minutes

时间窗: Assessed intraoperatively, 10 minutes after the initial confirmed placement of the device

The airway pressure at which an airway leak is observed 10 minutes after successful placement of the supraglottic airway

次要结局

  • Time for Successful Placement of the Supraglottic Airway(Assessed intraoperatively at the time of confirmed device placement)
  • Number of attempts to placement of Supraglottic Airway(Assessed intraoperatively at the time of confirmed device placement)
  • Fiberoptic Grade of Laryngeal View through Supraglottic Airway(Assessed intraoperatively at the time of confirmed device placement)
  • Gastric Tube Insertion Ease of Placement(Assessed intraoperatively at the time of confirmed gastric tube placement)
  • Gastric Tube Insertion Time(Assessed intraoperatively at the time of confirmed gastric tube placement)
  • Gastric Tube Insertion Attempts(Assessed intraoperatively at the time of confirmed gastric tube placement)
  • Postoperative Complications(Participants will be followed for the duration of hospital stay. Outcome measure will be assessed postoperatively in recovery unit.)
  • Intraoperative Complications(Assessed intraoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Narasimhan Jagannathan

Primary Investigator; M.D.

Ann & Robert H Lurie Children's Hospital of Chicago

研究点 (1)

Loading locations...

相似试验